1. Diagnostic and Therapeutic Considerations for Extramedullary Leukemia

   • Richard Bakst
   • Ann Powers
   • Joachim Yahalom

   Leukemia (A Aguayo, Section Editor) 24 June 2020 Article: 75

   

2. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers

   • Jennifer L. McQuade
   • Gabriel O. Ologun
   • Jennifer A. Wargo

   Melanoma (RJ Sullivan, Section Editor) 24 June 2020 Article: 74

   

3. Transitioning to a New Normal in the Post-COVID Era

   • Di M. Jiang
   • Alejandro Berlin
   • Srikala S. Sridhar

   Invited Commentary 22 June 2020 Article: 73

   

4. Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review

   • Jenica N. Upshaw

   Cardio-oncology (EH Yang, Section Editor) 20 June 2020 Article: 72

5. Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer

   • Kyuwan Lee
   • Judy Zhou
   • Christina M. Dieli-Conwright

   Cardio-oncology (EH Yang, Section Editor) 15 June 2020 Article: 71

   

6. Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development

   • Leandro Jonata Carvalho Oliveira
   • Aline Bobato Lara Gongora
   • Denis Leonardo Fontes Jardim

   Immuno-oncology (RM Bukowski and JH Finke, Section Editors) 12 June 2020 Article: 70

   

7. Management of the Small Renal Mass: a 2020 Update

   • Rand N. Wilcox Vanden Berg
   • Spyridon P. Basourakos
   • Timothy D. McClure

   Interventional Oncology (DC Madoff, Section Editor) 09 June 2020 Article: 69

   

8. Morcellation of the Uterus: Is There Any Place?

   • Michael J. Halaska
   • Myriam Gracia
   • Ignacio Zapardiel

   Gynecologic Cancers (NS Reed, Section Editor) 09 June 2020 Article: 68

   

9. Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

   • Valentina Bracun
   • Joseph Pierre Aboumsallem
   • Rudolf A. de Boer

   Cardio-oncology (EH Yang, Section Editor) Open access 09 June 2020 Article: 67

   

10. Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management

    • Perry Wu
    • Ohad Oren
    • Eric H. Yang

    Cardio-oncology (EH Yang, Section Editor) 08 June 2020 Article: 66

    

11. New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity

    • Arjun Khunger
    • Lucas Battel
    • Nikhil Agrawal

    Cardio-oncology (EH Yang, Section Editor) 08 June 2020 Article: 65